説明
Expression analysis of androgen synthesis enzymes (e.g., CYP17A1, AKR1C3) in melatonin-treated prostate cancer cells, showing suppression of the intracrine androgen pathway.
Figure 14
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 14: Expression analysis of androgen synthesis enzymes (e.g., CYP17A1, AKR1C3) in melatonin-treated prostate cancer cells, showing suppression of the intracrine androgen pathway.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Expression analysis of androgen synthesis enzymes (e.g., CYP17A1, AKR1C3) in melatonin-treated prostate cancer cells, showing suppression of the intracrine androgen pathway." /> <figcaption>Figure 14. Expression analysis of androgen synthesis enzymes (e.g., CYP17A1, AKR1C3) in melatonin-treated prostate cancer cells, showing suppression of the intracrine androgen pathway.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>